PH20413A - Crystalline human leukocyte interferon - Google Patents

Crystalline human leukocyte interferon

Info

Publication number
PH20413A
PH20413A PH28226A PH28226A PH20413A PH 20413 A PH20413 A PH 20413A PH 28226 A PH28226 A PH 28226A PH 28226 A PH28226 A PH 28226A PH 20413 A PH20413 A PH 20413A
Authority
PH
Philippines
Prior art keywords
human leukocyte
leukocyte interferon
crystalline human
interferon
crystalline form
Prior art date
Application number
PH28226A
Other languages
English (en)
Inventor
Hsiang-Fu Kung
David L Miller
Sidney Pestka
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PH20413A publication Critical patent/PH20413A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PH28226A 1981-12-07 1982-12-06 Crystalline human leukocyte interferon PH20413A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32787681A 1981-12-07 1981-12-07

Publications (1)

Publication Number Publication Date
PH20413A true PH20413A (en) 1987-01-05

Family

ID=23278463

Family Applications (1)

Application Number Title Priority Date Filing Date
PH28226A PH20413A (en) 1981-12-07 1982-12-06 Crystalline human leukocyte interferon

Country Status (12)

Country Link
EP (1) EP0083734B1 (da)
JP (1) JPS58164597A (da)
AT (1) ATE18410T1 (da)
AU (1) AU551407B2 (da)
CA (1) CA1209038A (da)
DE (1) DE3269727D1 (da)
DK (1) DK159164C (da)
IE (1) IE54374B1 (da)
IL (1) IL67411A0 (da)
NZ (1) NZ202698A (da)
PH (1) PH20413A (da)
ZA (1) ZA828917B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5441734A (en) * 1993-02-25 1995-08-15 Schering Corporation Metal-interferon-alpha crystals
CN1245215C (zh) 2001-02-28 2006-03-15 四川省生物工程研究中心 重组高效复合干扰素用作乙型肝炎表面抗原和e抗原抑制剂
US7585647B2 (en) 2003-08-28 2009-09-08 Guangwen Wei Nucleic acid encoding recombinant interferon

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA796175B (en) * 1978-11-24 1980-11-26 Hoffmann La Roche Purified proteins and process therefor

Also Published As

Publication number Publication date
DK538482A (da) 1983-06-08
NZ202698A (en) 1986-02-21
CA1209038A (en) 1986-08-05
DE3269727D1 (en) 1986-04-10
IE822882L (en) 1983-06-07
EP0083734B1 (de) 1986-03-05
AU551407B2 (en) 1986-05-01
JPH0477000B2 (da) 1992-12-07
DK159164C (da) 1991-02-11
ZA828917B (en) 1983-09-28
EP0083734A1 (de) 1983-07-20
AU9115582A (en) 1983-06-16
DK159164B (da) 1990-09-10
IL67411A0 (en) 1983-05-15
IE54374B1 (en) 1989-09-13
ATE18410T1 (de) 1986-03-15
JPS58164597A (ja) 1983-09-29

Similar Documents

Publication Publication Date Title
AU562938B2 (en) 7, 10, 13, 16 docosatetraenoic acid composition
GB2164349B (en) Process for preparing concentrated liquid c.i. direct yellow 11 in stable form by extended surface absorption during desalting
TW272968B (da)
GR3006807T3 (da)
DE3462852D1 (en) Medicament preparation for external use comprising adenosin for the treatment of herpes
DE3273611D1 (en) Infusion solutions for heart therapy
AU551407B2 (en) Crystalline human leukocyte interferon
DE3361263D1 (en) 2-acrylamido-2-methyl-propanephosphonic acids and their salts, process for their preparation
EP0407815A3 (en) Polyprenyl compound composition for soft capsules
GR77037B (da)
PL151373B2 (da)
IE872087L (en) Treating contact lenses
EP0215949A4 (en) PRODUCTION PROCESS 16-SUBSTITUTED PROSTAGLANDINE-E.
AU553275B2 (en) Stable oxytetracyclin solutions
EP0410652A3 (en) Improvement of excretion of potassium ion by prostanoic acid derivatives
FR2534916B1 (fr) Nouveaux derives de phenyl-(3-aminopropyl)-cetone, utilisation en therapeutique et procede de preparation
OA08918A (fr) Procédé d'enrichissement de la canallite par flottation.
Tanner The shaping art and vision of Howard O'Hagan: quest, belief and cycle in Tay John
PT79860A (en) Process for the preparation of 2-thiazoline and 2-oxozoline with antidote activity against non-selective herbicides
HRP940446B1 (en) Process for the preparation of 4,4'-dinitrostilbene-2,2'-sulfonic acid